can i take retatrutide UK 2026: Phase 3 Results Retatrutide Weight Loss Results:Trial Data

GLP-1 medications are prescription products requiring evaluation by a licensed clinician

MASLD was evaluated applying the (NAFLD) activity score (NAS), by allocating points for histological findings of steatosis, hepatocyte ballooning and inflammation activity 48

Source: Polaris Market Research Analysis Industry Developments February 2025: Biocon launched its GLP-1 peptide liraglutide in the UK under two brand names: Liraglutide Biocon (for diabetes, similar to Victoza) and Biolide (for chronic weight management, similar to Saxenda)

Challenges persist, however, including regulatory scrutiny across different regions concerning health claims, competition from established oral supplements and injectable GLP-1 agonists, and the need for robust clinical validation to support efficacy claims for topical applications